RM
Ramurthi Manda
About Ramurthi Manda
Data last updated:
Ramurthi Manda is a Director at Aabacus Formulations Private Limited (since 2024), Director at Aspen Biovet Private Limited (since 2026) and Director at Altuva Biotech Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Paper. The largest current company by reported revenue is Aabacus Formulations Private Limited at ₹16.4 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Jan 2024 | 2024 | ₹16.4 Lakh (FY 2025) | Active | |
| Director | 09 Oct 2026 | 2026 | Active | ||
| Director | 12 Mar 2025 | 2025 | Active | ||
| Director | 06 Mar 2025 | 2025 | Active |
Board colleagues of Ramurthi Manda
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gajjela Sai Ganesh | 10450398 | Aabacus Formulations Private Limited | Director |
| Manjula Bokka | 11184012 | Aspen Biovet Private Limited , Altuva Biotech Private Limited and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramurthi Manda
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramurthi Manda
Ramurthi Manda currently holds 4 directorships: Aabacus Formulations Private Limited (Director, since 02 Jan 2024, revenue ₹16.4 Lakh (FY 2025)); Aspen Biovet Private Limited (Director, since 09 Oct 2026); Altuva Biotech Private Limited (Director, since 12 Mar 2025); Collanovas Labs Private Limited (Director, since 06 Mar 2025).
Ramurthi Manda was first appointed on 02 Jan 2024 as Director at Aabacus Formulations Private Limited. The most recent appointment on record is 09 Oct 2026 at Aspen Biovet Private Limited.
The current boards of Ramurthi Manda's companies include Gajjela Sai Ganesh (Aabacus Formulations Private Limited), Manjula Bokka (Aspen Biovet Private Limited).